BR0309569A - Vacinas em combinação que incluem polipeptìdeos imunogênicos de fator camp e gapc - Google Patents

Vacinas em combinação que incluem polipeptìdeos imunogênicos de fator camp e gapc

Info

Publication number
BR0309569A
BR0309569A BR0309569-0A BR0309569A BR0309569A BR 0309569 A BR0309569 A BR 0309569A BR 0309569 A BR0309569 A BR 0309569A BR 0309569 A BR0309569 A BR 0309569A
Authority
BR
Brazil
Prior art keywords
gapc
factor
streptococcus
immunogenic polypeptides
camp
Prior art date
Application number
BR0309569-0A
Other languages
English (en)
Inventor
Alexandra J Bolton
Jose Perez-Casal
Michael Fontaine
Andrew A Potter
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Publication of BR0309569A publication Critical patent/BR0309569A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"VACINAS EM COMBINAçãO QUE INCLUEM POLIPEPTìDEOS IMUNOGêNICOS DE FATOR CAMP E GAPC". é descrito o uso de proteínas de ligação de plasmina de GapCde Streptococcus dysgalactiae (S. dysgalactiae), Strepbococcus agalactiae (S. agalactiae), Streptococcus uberis (S. uberis), Streptococcus parauberis (S. parauberis), e Streptococcus iniae (S. iniae) em combinação com fatores de CAMP, para prevenir ou tratar infecções bacterianas em geral, e mastite em particular.
BR0309569-0A 2002-04-26 2003-04-24 Vacinas em combinação que incluem polipeptìdeos imunogênicos de fator camp e gapc BR0309569A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/134,297 US6833134B2 (en) 2000-06-12 2002-04-26 Immunization of dairy cattle with GapC protein against Streptococcus infection
PCT/CA2003/000586 WO2003091279A2 (en) 2002-04-26 2003-04-24 COMBINATION VACCINES INCLUDING IMMUNOGENIC GapC AND CAMP FACTOR POLYPEPTIDES

Publications (1)

Publication Number Publication Date
BR0309569A true BR0309569A (pt) 2005-03-22

Family

ID=29268796

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0309569-0A BR0309569A (pt) 2002-04-26 2003-04-24 Vacinas em combinação que incluem polipeptìdeos imunogênicos de fator camp e gapc

Country Status (9)

Country Link
US (3) US6833134B2 (pt)
EP (1) EP1499634A2 (pt)
JP (1) JP2006503803A (pt)
AU (1) AU2003229415B2 (pt)
BR (1) BR0309569A (pt)
CA (1) CA2483453A1 (pt)
MX (1) MXPA04010645A (pt)
NZ (1) NZ536233A (pt)
WO (1) WO2003091279A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT103450B (pt) * 2006-03-13 2008-09-19 Univ Do Porto Vacina contra streptococcus agalactiae usando como antigénio alvo a proteína gliceraldeído-3-fosfato desidrogenase (gapdh) produzida pela bactéria, na sua forma nativa ou recombinante
PT2547361T (pt) 2010-03-17 2020-12-07 Socpra Sciences Et Genie Sec Componentes de vacina bacteriana de staphylococcus aureus e suas utilizações
EP2695938B1 (en) 2011-03-17 2016-11-30 National UniversityCorporation Mie University Antibody production method
CN103642802A (zh) * 2013-12-03 2014-03-19 中国水产科学研究院淡水渔业研究中心 吉富罗非鱼抗海豚链球菌感染家系的分子标记及筛选方法
NZ751880A (en) 2016-10-21 2023-04-28 Socpra Sciences Et Genie Sec Vaccine constructs and uses thereof against staphylococcus infections
CN114524880B (zh) * 2022-02-10 2023-09-19 黑龙江八一农垦大学 一种能够增强免疫原性和免疫保护作用的rtg融合蛋白

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE459503B (sv) 1985-05-03 1989-07-10 Excorim Kommanditbolag Hybrid-dna-molekyl innefattande dna-sekvens som kodar foer protein g samt foerfarande foer framstaellning av protein g
US4954618A (en) 1986-02-14 1990-09-04 Genex Corporation Cloned streptococcal genes encoding protein G and their use to construct recombinant microorganisms to produce protein G
US4977082A (en) 1987-12-10 1990-12-11 University Of Florida Research Foundation, Inc. Type VI bacterial FC receptors
US5472696A (en) 1988-02-26 1995-12-05 Univ. Of Florida Research Foundation, Inc. Antigen of group B streptococci
US5328996A (en) 1989-03-29 1994-07-12 University Of Florida Research Foundation, Inc. Bacterial plasmin receptors as fibrinolytic agents
US5237050A (en) 1989-03-29 1993-08-17 University Of Florida Research Foundation, Inc. Bacterial plasmin receptors as fibrinolytic agents
KR19990022742A (ko) 1995-06-07 1999-03-25 샤르레 아. 테시에르 스트렙토코커스 속 유래의 hsp70 계열의 쇼크 단백질
DK0832239T3 (da) 1995-06-08 2006-07-31 Univ Saskatchewan CAMP faktor af streptococcus uberis
US6936259B2 (en) 1995-06-08 2005-08-30 University Of Saskatchewan CAMP factor of Streptococcus uberis
US5863543A (en) 1996-06-05 1999-01-26 University Of Saskatchewan Camp factor of streptococcus uberis
EP0942983B2 (en) 1996-10-31 2014-09-10 Human Genome Sciences, Inc. Streptococcus pneumoniae antigens and vaccines
US6485904B1 (en) 1997-06-23 2002-11-26 Pfizer, Inc. DNA encoding a plasminogen activating protein
TR200002437T2 (tr) 1998-02-20 2000-11-21 Biochem Pharma Inc. B grubu streptococcus antijenleri.
BR9916477A (pt) 1998-12-23 2004-06-22 Shire Biochem Inc Polinucleotìdeo isolado, polinucleotìdeo quimérico, composição de vacina e uso desta composição compreendendo os polinucleotìdeos
CA2411919C (en) * 2000-06-12 2012-07-31 University Of Saskatchewan Immunization of dairy cattle with chimeric gapc protein against streptococcus infection
EP1332155B1 (en) 2000-06-12 2006-10-25 University of Saskatchewan Immunization of dairy cattle with gapc protein against streptococcus infection

Also Published As

Publication number Publication date
AU2003229415A1 (en) 2003-11-10
US20050089529A1 (en) 2005-04-28
JP2006503803A (ja) 2006-02-02
US20030165524A1 (en) 2003-09-04
US7273930B2 (en) 2007-09-25
WO2003091279A3 (en) 2004-03-18
MXPA04010645A (es) 2005-02-14
WO2003091279A2 (en) 2003-11-06
NZ536233A (en) 2006-04-28
CA2483453A1 (en) 2003-11-06
AU2003229415B2 (en) 2009-09-10
US20080213294A1 (en) 2008-09-04
EP1499634A2 (en) 2005-01-26
US7749516B2 (en) 2010-07-06
US6833134B2 (en) 2004-12-21

Similar Documents

Publication Publication Date Title
UY26783A1 (es) Antígenos de estreptococo.
BRPI0417823A (pt) métodos para uso de bifidobactérias probióticas para animais de estimação
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
CY1112560T1 (el) Πνευμονικη μεταφορα των αμινογλυκοσιδων
UA85574C2 (uk) Ендопаразитоцидний засіб для місцевого застосування
BRPI0410503B8 (pt) composição tópica e uso da composição
UA89798C2 (ru) Стабильный водный препарат антитела в гистидинацетатном буфере
BR0312506A (pt) Composições transdérmicas de toxina botulìnica
BRPI0511420A (pt) fosforodiamidatos de sulfoniletila
BRPI0407234A (pt) Heterociclos substituìdos
BR0208874A (pt) Proteìnas superficiais de streptococcus pyogenes
CU23260B7 (es) PREPARADO FARMACéUTICO DE MOXIFLOXACINA
DK2054431T3 (da) Konformere af bakterielle adhæsiner
BRPI0406858A (pt) Liberação controlada de agentes altamente solúveis
ATE362481T1 (de) Lantibiotikum
CL2004001012A1 (es) Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica
WO2000058475A3 (en) Streptococcus pneumoniae antigens
WO2003032985A3 (en) Concomitant oral and topical administration of anti - infective agents
BR0309569A (pt) Vacinas em combinação que incluem polipeptìdeos imunogênicos de fator camp e gapc
EA200400197A1 (ru) Способы получения поливалентных бактериофагов для лечения бактериальных инфекций
MX2007011381A (es) Composicion de espirulinas rica en principios activos, su proceso de obtencion y su utilizacion.
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
PT1255538E (pt) Utilizacao do acido 2-metil-tiazolidin-2,4-dicarboxilico e/ou sais compativeis fisiologicamente para tratamento e/ou prevencao de cancros

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O C/C 13, 10 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.